The company aims to boost its investment in biotechnology and biosimilars, focusing on an approximate sector price of USD 25 billion in India by 2025. Wockhardt's initiatives to scale up production capabilities are evident, with ideas to enhance manufacturing capacity by 30% above the next two years. Seeking ahead, Wockhardt https://worldwidepsychedelics.com/product/buy-codeine-online/